🍽️ betaxolol hydrochloride,(prescription)

AI Engines For more Details: Perplexity  Kagi Labs  You 

Check for interactions on Supp.AI   |   📚 PubMed Citations

⚗️ Compensation for antibiotic usage

(apixol 0.5%, betac, betax, betaxol, betaxolol andromaco, betaxolol borg, betaxolol l.ch., betaxolol winthrop, betopric, betoptic, betoptic 0.5%, betoptic s, betoptic-s, eifel, glucovis, iobet, kerlone, ketaxol, keval, optibetol, rialol, along, beof, bertocil, betakyl 0.5%, betalmic, betalmic 0.5%, betamed, betarun, betasel, betaxa, betaxen, betaxolol 0.5%, betaxolol biogaran, betaxolol eg, betaxolol hydrochloride kvk-tech, betaxolol hydrochloride teva, betaxolol medochemie, betaxolol mylan, betaxolol pmcs, betaxolol sandoz, betaxolol teva sante, betaxon 0.5%, betoftan, betoptic 0.25%, betoptic s 0.25%, betoptic s 0.5%, betoptima, bexolo, cloridrato de betaxolol, kefnan, kerlon, kerlone mite, kerlong, lokren, optibet, optibetol 0.5%, presmin, sandoz betaxolol, tarlong)

Data Contradictions — Limits of Certainity

Impacted of betaxolol hydrochloride,(prescription) On Probiotics

Rank	Probiotic	Impact
species	Lacticaseibacillus paracasei	Reduces

Bacteria Impacted by betaxolol hydrochloride,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

🧙?

📓 Direct Citations	👪👶 Indirect Citations	Taxonomy	Rank	Effect
0	1	Dorea	genus	Decreases
0	1	Roseburia	genus	Decreases
0	1	Agathobacter	genus	Decreases
0	1	Lacrimispora	genus	Decreases
0	1	Odoribacter	genus	Decreases
0	1	Thomasclavelia	genus	Decreases
0	1	Lacticaseibacillus	genus	Decreases
1	0	Lacticaseibacillus paracasei	species	Decreases
1	0	Roseburia intestinalis	species	Decreases
1	0	Lacrimispora saccharolytica	species	Decreases
1	0	Thomasclavelia ramosa	species	Decreases
1	0	Odoribacter splanchnicus	species	Decreases
1	0	Dorea formicigenerans	species	Decreases
1	0	Agathobacter rectalis	species	Decreases
0	1	Lacticaseibacillus paracasei subsp. paracasei	subspecies	Decreases
0	1	Lacticaseibacillus paracasei subsp. tolerans	subspecies	Decreases

Impact of betaxolol hydrochloride,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition	Positive Impact	Negative Impact	Benefit Ratio Impact
ADHD	1.1		1.1
Age-Related Macular Degeneration and Glaucoma	1.1		1.1
Allergic Rhinitis (Hay Fever)	0.6		0.6
Allergies	0	0.6	0
Alopecia (Hair Loss)	0.6		0.6
Alzheimer's disease	1.4	1.5	-0.07
Amyotrophic lateral sclerosis (ALS) Motor Neuron	0.9	0.5	0.8
Ankylosing spondylitis	0.6		0.6
Anorexia Nervosa		1.1	-1.1
Antiphospholipid syndrome (APS)	0.4		0.4
Asthma	1.4	0.5	1.8
Atherosclerosis		1	-1
Atrial fibrillation	0.9	0	0
Autism	1.4	1.4	0
Autoimmune Disease		0.5	-0.5
Bipolar Disorder		0.5	-0.5
Brain Trauma		0.5	-0.5
Cancer (General)	0.3	0.6	-1
Carcinoma	0.9	0.9	0
Celiac Disease	0.7	0.9	-0.29
Cerebral Palsy		0.5	-0.5
Chronic Fatigue Syndrome	0	0.7	0
Chronic Kidney Disease	0.6	0.6	0
Chronic Lyme		0.5	-0.5
Chronic Obstructive Pulmonary Disease (COPD)		0.5	-0.5
Coagulation / Micro clot triggering bacteria		0.5	-0.5
Cognitive Function	1.1	0.8	0.38
Colorectal Cancer	0.8	0.8	0
Constipation		0.5	-0.5
Coronary artery disease	0.3	0.8	-1.67
COVID-19	0.6	2.3	-2.83
Crohn's Disease	1.4	1.4	0
cystic fibrosis		0.5	-0.5
deep vein thrombosis	0.5	0.5	0
Depression	2.1	2.4	-0.14
Eczema		0.6	-0.6
Endometriosis	0.6	0.8	-0.33
erectile dysfunction	0.3		0.3
Fibromyalgia	1.4	0.5	1.8
Functional constipation / chronic idiopathic constipation	0.7	0.5	0.4
gallstone disease (gsd)	0.6	0.5	0.2
Generalized anxiety disorder		0.5	-0.5
Graves' disease		1.1	-1.1
Hashimoto's thyroiditis	1.1		1.1
Heart Failure		0.6	-0.6
hemorrhagic stroke	0.6		0.6
High Histamine/low DAO	0.5		0.5
hypercholesterolemia (High Cholesterol)	0.3		0.3
hypertension (High Blood Pressure	0.6	0.8	-0.33
Hypoxia	0.6		0.6
IgA nephropathy (IgAN)		0.5	-0.5
Inflammatory Bowel Disease	0.4	1.5	-2.75
Insomnia	0.6	0.8	-0.33
Irritable Bowel Syndrome	1.1	0.5	1.2
ischemic stroke		0.8	-0.8
Liver Cirrhosis	1.7	1.1	0.55
Long COVID	0.9	1.7	-0.89
Low bone mineral density		0.5	-0.5
Lung Cancer		0.6	-0.6
ME/CFS with IBS		0	0
ME/CFS without IBS		0.6	-0.6
Menopause		0.5	-0.5
Metabolic Syndrome	1.4	1.4	0
Mood Disorders	1.4	1.4	0
Multiple Sclerosis	0.6	0.6	0
myasthenia gravis		0.5	-0.5
neuropathic pain		0.6	-0.6
Neuropathy (all types)		0.6	-0.6
neuropsychiatric disorders (PANDAS, PANS)	0.3		0.3
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic	1.7	0.8	1.13
Obesity	1.5	2	-0.33
obsessive-compulsive disorder		1.2	-1.2
Osteoarthritis	0.3		0.3
Osteoporosis	0.5	0.6	-0.2
pancreatic cancer	0.3		0.3
Parkinson's Disease	0.8	2.5	-2.13
Polycystic ovary syndrome	0.5	0.8	-0.6
primary biliary cholangitis	0.6		0.6
Psoriasis	0	0.6	0
rheumatoid arthritis (RA),Spondyloarthritis (SpA)	1.2	1.4	-0.17
Rosacea		0.5	-0.5
Schizophrenia	0.3	0.5	-0.67
Sjögren syndrome	0.3	0.9	-2
Sleep Apnea	0.6	0.5	0.2
Stress / posttraumatic stress disorder	1.1	0.5	1.2
Systemic Lupus Erythematosus	0.3	1.2	-3
Tic Disorder	0.3	0.6	-1
Tourette syndrome	0.6		0.6
Type 1 Diabetes	0.6	0.5	0.2
Type 2 Diabetes	1.7	1.1	0.55
Ulcerative colitis	0.9	1.2	-0.33
Unhealthy Ageing	0.6	0.8	-0.33